In recent years, the interest surrounding natural health supplements has skyrocketed, with consumers seeking products that enhance their well-being without the side effects commonly associated with ...

AbbVie has claimed its first regulatory approval, from the FDA, for its C-met-targeting antibody-drug conjugate (ADC) Emrelis as a treatment for a type of lung cancer. The US regulator cleared ...